UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000040543
Receipt No. R000045412
Scientific Title Characterization of gut microbiome in patients with lung adenocarcinoma
Date of disclosure of the study information 2020/06/01
Last modified on 2020/05/27

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Characterization of gut microbiome in patients with lung adenocarcinoma
Acronym Characterization of gut microbiome in patients with lung adenocarcinoma
Scientific Title Characterization of gut microbiome in patients with lung adenocarcinoma
Scientific Title:Acronym Characterization of gut microbiome in patients with lung adenocarcinoma
Region
Japan

Condition
Condition lung adenocarcinoma
Classification by specialty
Pneumology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To assess the relationship between gut microbiome and lung adenocarcinoma
Basic objectives2 Others
Basic objectives -Others To assess the relationship between gut microbiome and lung adenocarcinoma
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes gut microbiome
Key secondary outcomes none

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit

Not applicable
Gender Female
Key inclusion criteria patients with lung adenocarcinoma who agree to this study.
Key exclusion criteria patients who do not agree to this study and those who are not appropriate for this study.
Target sample size 50

Research contact person
Name of lead principal investigator
1st name Tatsuya
Middle name
Last name Nagano
Organization Kobe University School of medicine
Division name Division of Respiratory Medicine
Zip code 650-0017
Address 7-5-2 Kusunoki-cho Chuo-ku Kobe City
TEL 078-382-5660
Email tnagano@med.kobe-u.ac.jp

Public contact
Name of contact person
1st name Tatsuya
Middle name
Last name Nagano
Organization Kobe University Hospital
Division name Division of Respiratory Medicine
Zip code 650-0017
Address 7-5-2 Kusunoki-cho Chuo-ku Kobe City
TEL 078-382-5660
Homepage URL
Email tnagano@med.kobe-u.ac.jp

Sponsor
Institute Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine
Institute
Department

Funding Source
Organization Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor National institutes of biomedical innovation, health and nutrition
Name of secondary funder(s)

IRB Contact (For public release)
Organization Kobe University Hospital
Address 7-5-2 Kusunoki-cho Chuo-ku Kobe City
Tel 078-382-6669
Email chiken@med.kobe-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2020 Year 06 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2020 Year 05 Month 26 Day
Date of IRB
2020 Year 05 Month 26 Day
Anticipated trial start date
2020 Year 05 Month 27 Day
Last follow-up date
2027 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information observational study

Management information
Registered date
2020 Year 05 Month 27 Day
Last modified on
2020 Year 05 Month 27 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045412

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.